Skip to main content

Table 2 Baseline characteristics of patients in the training cohort [n(%)]

From: Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study

Variables Death (n = 22) Discharge (n = 102) P
Gender
 Male 14 (63.6) 55 (53.9) 0.407
Comorbidity 0.005
 Without comorbidity 1 (4.6) 30 (29.4)  
 With single comorbidity 6 (27.3) 32 (31.4)  
 With multiple comorbidity 15 (68.1) 40 (39.2)  
 Smoke 13 (59.1) 53 (52.0) 0.545
 Panting (breathing rate ≥ 30/min) 17 (77.3) 39 (38.2) 0.001
WBC (×109/L) 0.001
  >  10 10 (45.5) 14 (13.7)  
  ≤ 10 12 (54.5) 88 (86.3)  
Lymphocyte (×109/L) < 0.001
  > 1.0 2 (9.1) 54 (52.9)  
  ≤ 1.0 20 (90.9) 48 (47.1)  
Neutrophil (×109/L) 0.001
  >  6.3 13 (59.1) 23 (22.6)  
  ≤ 6.3 9 (40.9) 79 (77.4)  
PLT (×109/L) 0.076
  ≥ 100 18 (81.8) 96 (94.1)  
  < 100 4 (18.2) 6 (5.9)  
CRP (mg/L) 0.008
  >  10 18 (81.8) 52 (51.0)  
  ≤ 10 4 (18.2) 50 (49.0)  
D-dimer (mg/L) 0.006
  > 0.55 20 (90.9) 61 (59.8)  
  ≤ 0.55 2 (9.1) 41 (40.2)  
PCT (ng/ml) 0.020
  > 0.05 20 (90.9) 67 (65.7)  
  ≤ 0.05 2 (9.1) 35 (34.3)  
IL-6 (pg/ml) < 0.001
  ≥ 10 21 (95.5) 47 (46.1)  
  < 10 1 (4.5) 55 (53.9)  
SaO2 on admission 0.294
  ≥ 90% 13 (59.1) 72 (70.6)  
  <  90% 9 (40.9) 30 (29.4)  
TBIL (μmol/L) 0.326
  ≥ 20 10 (45.5) 35 (34.3)  
  <  20 12 (54.5) 67 (65.7)  
ALT (U/L) 0.147
  ≥ 40 9 (40.9) 26 (25.5)  
  <  40 13 (59.1) 76 (74.5)  
AST (U/L) 0.213
  ≥ 40 10 (45.5) 31 (30.4)  
  <  40 12 (54.5) 71 (69.6)  
LDH (U/L) 0.352
  ≥ 245 14 (63.6) 75 (73.5)  
  <  245 8 (36.4) 27 (26.5)  
γ-GT (U/L) 0.441
  ≥ 50 13 (59.1) 51 (50.0)  
  <  50 9 (40.9) 51 (50.0)  
Cr (μmol/L) 0.718
  > 80 8 (36.4) 33 (32.4)  
  ≤ 80 14 (63.6) 69 (67.6)  
  1. WBC White blood cell, PLT Platelet, CRP C-reactive protein, PCT Procalcitonin, IL-6 Interleukin-6, SaO2 Oxygen saturation, TBIL Total bilirubin, ALT Alanine aminotransferase, AST Aspartate aminotransferase, LDH Lactate dehydrogenase, γ-GT γ-glutamyl transpeptadase, Cr Creatinine